Clinical Trial Update: Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

View source ↗

Summary

A Stanford-sponsored clinical trial evaluating allogeneic transplantation for acute and chronic leukemias has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia

Snippet

Sponsor: Stanford University | Conditions: Leukemia, Lymphocytic, Acute, Leukemia | Status: TERMINATED